A detailed history of Formula Growth LTD transactions in Dexcom Inc stock. As of the latest transaction made, Formula Growth LTD holds 48,148 shares of DXCM stock, worth $3.55 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
48,148
Previous 25,548 88.46%
Holding current value
$3.55 Million
Previous $1.71 Million 118.69%
% of portfolio
1.35%
Previous 0.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$65.68 - $81.01 $1.48 Million - $1.83 Million
22,600 Added 88.46%
48,148 $3.74 Million
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $11,520 - $20,890
-180 Reduced 0.7%
25,548 $1.71 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $515,147 - $655,901
4,670 Added 22.18%
25,728 $2.92 Million
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $84,751 - $103,954
-742 Reduced 3.4%
21,058 $2.92 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $1.65 Million - $2.71 Million
21,800 New
21,800 $2.71 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.